Rethinking the Cost-Benefit of PSA Tests

Was this Fixing U.S. Healthcare blog wrong to single out PSA as not worth its cost? This was the claim in two previous posts, including the overall most popular one, The Problem of Diminishing Marginal Benefit in Healthcare. Some new information suggests that we need to rethink that original claim. Prostate Specific Antigen Since prostate … Continue reading Rethinking the Cost-Benefit of PSA Tests

Healthcare Reform: Are Insurance Companies and Drug Companies the Culprits?

“We are at the mercy of the private insurance and pharmaceutical companies, whose greed dictates the cost of healthcare,” railed Democrat Presidential candidate Senator Bernie Sanders in a recent campaign blurb. Are insurance and drug companies really the ones to blame for our healthcare problem – unsustainable costs and millions without access?  If so, are … Continue reading Healthcare Reform: Are Insurance Companies and Drug Companies the Culprits?